Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Down – Time to Sell?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) gapped down prior to trading on Friday . The stock had previously closed at $7.40, but opened at $7.0801. Coloplast A/S shares last traded at $7.12, with a volume of 6,298 shares.

Analysts Set New Price Targets

Separately, Kepler Capital Markets upgraded Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold”.

Coloplast A/S Stock Down 1.8%

The business’s 50 day simple moving average is $6.56 and its 200 day simple moving average is $6.59. The company has a current ratio of 1.75, a quick ratio of 1.09 and a debt-to-equity ratio of 1.66. The firm has a market capitalization of $16.11 billion, a PE ratio of 37.63, a PEG ratio of 2.79 and a beta of 0.16.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.10. Coloplast A/S had a net margin of 9.68% and a return on equity of 38.81%. The firm had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.11 billion. On average, equities research analysts forecast that Coloplast A/S Sponsored ADR will post 0.4 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.